Cell and Gene Therapy Industry - Source Material Survey

In a survey of >25 US blood centers' annual donor data 2010-2020 inclusive, donations were down in all age groups <55 (even after being normalized for COVID impacts) and donations in most age group were down 21-64%.

Access to large numbers of geographically dispersed and ethnically diverse donors of human blood-derived cells and cellular material of all types (healthy, sick, rare, etc) for use in R&D, testing, manufacturing reagents, and human therapeutics has been described, by some, as critical for the continued evolution of the cell and gene therapy industry.

We aim to gather and share intel on this potential emerging issue. Please participate in this survey to power sector intelligence.

Cell and Gene Therapy Industry Survey

Your participation is much appreciated!